Janssen Korea

Latest Headlines

Latest Headlines

J&J consumer healthcare faces more issues, this time in Brazil

Johnson & Johnson just can't seem to get its consumer health manufacturing in order.

Gorsky pleads with employees to think quality

Another Big Pharma CEO is having a pep talk with employees about manufacturing lapses and the need to reflect on quality.

CEO of J&J OTC unit in Korea faces criminal action over plant foul-up

Problems at a Janssen over-the-counter plant in Korea have gone from unfortunate to very serious now that authorities there intend to pursue criminal charges. This tack means Kim Oak-yeon, CEO of the Johnson & Johnson ($JNJ) subsidiary in South Korea, faces up to three years in jail if convicted.